Core Laboratories Inc Stock Price, News & Analysis

Core Laboratories (NYSE: CLB) reported Q3 2025 revenue of $134.5M, GAAP operating income of $20.9M and GAAP EPS of $0.30. Operating income, ex-items, was $16.6M and EPS, ex-items, was $0.22. The company generated $6.5M free cash flow, repurchased 462,248 shares for $5.0M (≈1% of outstanding shares), and reduced net debt by $3.4M to $91.4M, lowering leverage to 1.10. On Oct 1, 2025 Core completed the acquisition of Brazil-based Solintec for an initial cash payment of $2.3M plus an earnout up to $3.7M. Q4 2025 guidance: revenue $132M–$136M, operating income $14M–$16.1M, EPS $0.18–$0.22. The Board approved a quarterly cash dividend of $0.01 per share.

Core Laboratories (NYSE: CLB) has announced the strategic acquisition of Solintec, a leading Brazil-based integrated geological services company. The acquisition strengthens Core Lab's presence in Brazil's oil and gas sector, where Solintec has been serving national and international companies for over 30 years.

Solintec's modern laboratory facilities provide in-country mineralogic and sedimentary analysis capabilities, which, combined with Core Lab's proprietary dual-energy tomography, will enhance geological assessment services for Brazil's complex offshore pre-salt and onshore projects. The companies have been collaborating through a technical services arrangement since 2022.

This strategic move aligns with Core Lab's investment strategy in key growth markets, positioning the company to capitalize on Brazil's emergence as a leading non-OPEC producer.

Core Laboratories (NYSE:CLB), a global leader in reservoir description and production enhancement services, has scheduled its Q3 2025 earnings conference call for October 23, 2025, at 7:30 a.m. CDT. The company will release its earnings report after market close on October 22, 2025.

The call will feature CEO Larry Bruno, CFO Chris Hill, and SVP Corporate Development Gwen Gresham discussing financial and operational results. Investors can access the webcast through Core Laboratories' website, with replay and transcript available post-call.

Core Laboratories (NYSE:CLB) reported Q2 2025 results with revenue of $130.2 million, up 5% sequentially but flat year-over-year. Operating income was $15.3 million, with operating margins ex-items of 11%. The company posted GAAP EPS of $0.22 (ex-items $0.19).

The Reservoir Description segment generated revenue of $86.3 million, up 7% sequentially, while Production Enhancement posted revenue of $43.9 million, up 3% sequentially. Core Lab opened a new Unconventional Core Analysis Laboratory in Dammam, Saudi Arabia, strengthening its Middle East presence.

The company generated free cash flow of $10.4 million, reduced net debt by $9.1 million, and improved its debt leverage ratio to 1.27. Core Lab repurchased 237,632 shares worth $2.7 million and declared a quarterly dividend of $0.01 per share.

Core Laboratories (NYSE: CLB), a global leader in reservoir description and production enhancement services, has scheduled its second quarter 2025 earnings conference call for July 24, 2025, at 7:30 a.m. CDT / 8:30 a.m. EST. The earnings release will be issued after market close on July 23, 2025.

The company's leadership team, including CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham, will discuss financial and operational results. Investors can access the webcast through Core Laboratories' website, with replay and transcript available post-call. The company maintains a strong global presence with over 70 offices across more than 50 countries.

Core Laboratories (NYSE: CLB) has announced the opening of a new Unconventional Core Analysis Laboratory in Dammam, Saudi Arabia, developed in partnership with Abdulla Fouad Group. The state-of-the-art facility features advanced proprietary instrumentation for comprehensive core and fluid analysis services focused on unconventional reservoirs.

The laboratory utilizes cutting-edge technologies including dual energy CT-scanning, high-frequency Nuclear Magnetic Resonance (NMR), and Core's proprietary PRISM™ workflow to provide detailed reservoir rock and fluid characterization. CEO Larry Bruno emphasized that this expansion represents a significant milestone in supporting the energy sector's evolving needs. The facility aims to become a central hub for unconventional core analysis in the Middle East region.

Core Laboratories (NYSE: CLB) reported Q1 2025 results with revenue of $123.6 million, declining 4% sequentially and 5% year-over-year. Operating income was $4.4 million, while operating income ex-items reached $11.8 million with 10% margins. The company posted GAAP EPS of $0.00 and EPS ex-items of $0.14.

Key financial highlights include:

• Free cash flow of $3.9 million, up over 50% year-over-year
• Net debt reduced by $4.9 million, maintaining a leverage ratio of 1.31
• Repurchased 131,598 shares worth $2.0 million
• Quarterly dividend of $0.01 per share announced

Performance was impacted by seasonal declines, geopolitical conflicts, expanded sanctions, and pending tariffs. The company's Reservoir Description segment revenue was $80.9 million, while Production Enhancement posted revenue of $42.7 million. For Q2 2025, Core Lab projects revenue between $128-134 million with operating income of $13.1-15.7 million.

Core Laboratories (NYSE: CLB) has scheduled its first quarter 2025 earnings conference call for April 24, 2025, at 7:30 a.m. CDT / 8:30 a.m. EST. The company will release its earnings report after market close on April 23, 2025.

The conference call will feature Larry Bruno (Chairman and CEO), Chris Hill (CFO), and Gwen Gresham (SVP Corporate Development and Investor Relations) discussing financial and operational results. Investors can access the webcast through the company's website, with replay and transcript available after the call.

Core Laboratories operates in over 70 offices across more than 50 countries, providing reservoir description and production enhancement services for the petroleum industry.

Core Laboratories (CLB) reported Q4 2024 revenue of $129.2M, down 4% sequentially but slightly up year-over-year, with operating income of $14.2M. Q4 GAAP EPS was $0.15, while EPS ex-items reached $0.22. The company generated strong free cash flow of $16.2M, up over 50% sequentially.

For full year 2024, revenue increased 3% to $523.8M, with operating income ex-items of $65.3M, up 7%. Full year EPS ex-items grew 9% to $0.87. The company reduced its net debt by $42M during 2024, achieving a debt leverage ratio of 1.31.

The Reservoir Description segment, representing 80% of international revenue, posted Q4 revenue of $86.8M, while Production Enhancement recorded $42.4M. During Q4, CLB repurchased 264,982 shares for $4.9M and maintained its quarterly dividend of $0.01 per share.